Autoimmune Disorders - Current Concepts and Advances From Bedside to Mechanistic Insights 2011
DOI: 10.5772/20848
|View full text |Cite
|
Sign up to set email alerts
|

Primary Sjögren’s Syndrome: Current Pathophysiological, Diagnostic and Therapeutic Advances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 164 publications
0
2
0
Order By: Relevance
“…SS is classified as either primary, when occurring alone, or secondary, when occurring along with another autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus or myositis. Although the origin of the disease remains unknown, epithelial cell activation is considered to play a central role in the multifactorial pathogenesis of SS [ 67 , 68 , 69 , 70 ]. Several autoantibodies have been detected in patients suffering from SS and associated with clinical features of SS; including against ribonucleoproteins (Ro/SS-A) and La/SS-B), CA19-9, muscarinic M3 receptors and pancreatic ductal cells [ 71 , 72 , 73 , 74 ].…”
Section: Aquaporins and Pathophysiological Conditionsmentioning
confidence: 99%
“…SS is classified as either primary, when occurring alone, or secondary, when occurring along with another autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus or myositis. Although the origin of the disease remains unknown, epithelial cell activation is considered to play a central role in the multifactorial pathogenesis of SS [ 67 , 68 , 69 , 70 ]. Several autoantibodies have been detected in patients suffering from SS and associated with clinical features of SS; including against ribonucleoproteins (Ro/SS-A) and La/SS-B), CA19-9, muscarinic M3 receptors and pancreatic ductal cells [ 71 , 72 , 73 , 74 ].…”
Section: Aquaporins and Pathophysiological Conditionsmentioning
confidence: 99%
“…As a consequence, AQPs inhibitors and gene therapy using viral vectors encoding AQPs have been developed [31,33,34,35,36,37,38]. In addition, AQPs are potential biomarkers for the diagnosis and prognosis of diseases, and in particular of cancers [29,39,40,41,42,43,44,45,46,47,48,49,50].…”
Section: Introductionmentioning
confidence: 99%